The U.S. Food and Drug Administration (FDA) announced it would hold a meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) on Sept. 8 to discuss regulatory approaches for use of gadolinium-based contrast agents (GBCAs).

September 7, 2017 — Median Technologies announced that it will lead a scientific and medical roundtable on Sept. 7 in Sophia-Antipolis, France, to discuss the application of its next-generation imaging platform iBiopsy for nonalcoholic steatohepatitis (NASH). The roundtable panel will include four key opinion leaders:

September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective for some patients. Research highlighted in the featured article of the September issue of The Journal of Nuclear Medicine demonstrates that combined positron emission tomography/computed tomography (PET/CT) scanning early in treatment could identify whether the therapy will benefit a particular patient.

Regional One Health (Memphis, Tenn.) has implemented Carestream Health’s Clinical Collaboration Platform  that includes enterprise imaging, vendor-neutral archiving and Vue Motion universal viewer.

The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens Healthineers that integrates ultrasound and angiography to guide cardiac teams when administering treatment for structural heart disease. Available on the new Release 5.0 of the Acuson SC2000 cardiovascular ultrasound system, TrueFusion is designed to maximize not only interventional cardiology procedures, but also routine diagnosis and follow-up of patients with structural heart disease.

A new study by the Harvey L. Neiman Health Policy Institute found that in the Medicare population, the utilization rates have increased in both volume and per beneficiary over the past two decades for the most common musculoskeletal (MSK) extremity imaging modalities. The study focused on radiography, magnetic resonance imaging (MRI), computed tomography (CT) and ultrasound.

MRI Distortion Check is a new, cloud-based solution designed to quickly and automatically quantify distortion in magnetic resonance images (MRI). Used in conjunction with CIRS MRI Grid phantoms, the software provides the capability to quickly and accurately measure distortion through out the entire image volume.

September 6, 2017 — Guerbet LLC USA announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (gadoterate meglumine) for intravenous use with magnetic resonance imaging (MRI) in pediatric patients under two years old, including term neonates.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now